704256006: Vedolizumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Immunosuppressant (substance)\Vedolizumab
\Drug or medicament (substance)\Monoclonal antibody\Vedolizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Vedolizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Vedolizumab

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Vedolizumab
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Vedolizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3011048012 Vedolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3011945013 Vedolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
849061000172112 védolizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
849071000172115 vedolizumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vedolizumab	Is a	Monoclonal antibody agent	false	Inferred relationship	Some
Vedolizumab	Is a	Alpha-4 integrin receptor antagonist	true	Inferred relationship	Some
Vedolizumab	Is a	Monoclonal antibody	true	Inferred relationship	Some
Vedolizumab	Has disposition (attribute)	Alpha-4 integrin receptor antagonist (disposition)	true	Inferred relationship	Some
Vedolizumab	Has disposition (attribute)	Immunomodulator (disposition)	true	Inferred relationship	Some
Vedolizumab	Is a	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Vedolizumab	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has active ingredient	False	Vedolizumab	Inferred relationship	Some
Product containing vedolizumab (medicinal product)	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Product containing only vedolizumab (medicinal product)	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab therapy (procedure)	Direct substance	True	Vedolizumab	Inferred relationship	Some	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab-containing product in parenteral dose form	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Product containing only vedolizumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 158.824 mg/mL solution for injection	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 158.824 mg/mL solution for injection	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion vial	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion vial	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial	Has precise active ingredient	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial	Has basis of strength substance (attribute)	True	Vedolizumab	Inferred relationship	Some	1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug